Literatur

AHRQ Nationwide Inpatient sample.
Healthcare Cost and Utilisation Project. Agency for Healthcare Research and Quality, Rockville MD.
www.hcup.ahrq.gov/HCUPnet.asp (Recherchedatum: 11.06.2007).

American Society of Health-System Pharmacists (ASHP).
Therapeutic guidelines on antimicrobial prophylaxis in surgery.
www.ashp.org/s_ashp/bin.asp?CID=517&DID=5518&DOC=FILE.PDF (Recherchedatum: 11.06.2007).

Arbeitskreis Krankenhaushygiene der AWMF.
Empfehlungen zur Hygiene in Klinik und Praxis.
www.hygiene-klinik-praxis.de/ (Recherchedatum: 11.06.2007).

Bernasconi E, Francioli P.
Empfehlungen zur perioperativen Antibiotikaprophylaxe.
Swiss NOSO 2000; 7 (2): 9-16.

Berry DJ, von Knoch M, Schleck CD, Harmsen WS.
The Cumulative Long-Term Risk of Dislocation. After Primary Charnley Total Hip Arthroplasty.
The Journal of Bone and joint surgery 2004; 86-A (1): 9-14.

Block JE, Stubbs HA.
Reducing the risk of deep wound infection in primary joint arthroplasty with antibiotic bone cement.
Orthopedics 2005; 28 (11): 1334-1345.

Callaghan JJ et al.
Orthopaedic knowledge update Hip and knee reconstruction, developed by the Hip Society and the knee society. 1st ed.
Philadelphia, Lippincott. Williams & Wilkins; 1995.

Dellinger RP, Carlet J, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent J-L, Levy MM.
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.
Intensive Care Med 2004; 30: 536-555.

Dimick JB, Welch HG, Birkmeyer JD.
Surgical mortality as an indicator of hospital quality: the problem with small sample size.
JAMA 2004; 292(7): 847-851.

Dorr LD, Wan Z.
Causes of and Treatment Protocol for Instability of Total Hip Replacement.
Clinical Orthopaedics and related Research 1998; 355: 144-151.

Gristina AG, Costerton JW.
Bacterial adherence and the glycocalyx and their role in musculoskeletal infection.
Orthop Clin North Am 1984; 15 (3): 517-535.

Hedlundh U, Karlsson M, Ringsberg K, Besjakov J, Fredin H.
Muscular and neurologic function in patients with recurrent dislocation after total hip arthroplasty: a matched controlled study of 65 patients using dual-energy X-ray absorptiometry and postural stability tests.
J Arthroplasty 1999; 14 (3): 319-325.

Judge A, Chard J, Learmonth I, Dieppe P.
The effects of surgical volumes and training centre status on outcomes following total joint replacement: analysis of the Hospital Episode Statistics for England.
J Public Health 2006; 28 (2): 116-124.

Khuri SF, Daley J, Henderson W, Hur K, Hossain M, Soybel D, Kizer K, Aust JB, Bell RH Jr, Chong V, Demakis J, Fabri PJ, Gibbs JO, Grover F, Hammermeister K, McDonald G, Passaro E Jr, Phillips L, Scamman F, Spencer J, Stremple JF,
VA National Surgical Quality Improvement Program. Relation of surgical volume to outcome in eight common operations.
Annals of Surgery 1999; 230 (3): 414-432.

Kohn D, Rühmann O, Wirth CJ.
Die Verrenkung der Hüfttotalendoprothese unter besonderer Beachtung verschiedener Zugangswege.
Z Orthop 1997; 135: 40-44.

Li E, Meding JB, Ritter MA, Keating EM, Faris PM.
The natural history of a posteriorly dislocated total hip replacement.
J Arthroplasty 1999; 14 (8): 964-968.

Linsell L, Dawson J, Zondervan K, Rose P, Carr A, Randall T, Fitzpatrick R.
Pain and overall health status in older people with hip and knee replacement: a population perspective.
J Public Health 2006; 28 (3): 267-273.

Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA.
Rates and Outcomes of Primary and Revision Total Hip Replacement in the United States Medicare Population.
The Journal of Bone and joint surgery 2003; 85-A (1): 27-32.

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR.
Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee.
Am J Infect Control 1999; 27 (2): 97-132.

Masonis JL, Bourne RB.
Surgical approach, abductor function, and total hip arthroplasty dislocation.
Clin Orthop 2002; (405): 46-53.

Merx H, Dreinhöfer K, Schräder P, Stürmer T, Puhl W, Günther K-P, Brenner H.
International variation in hip replacement rates.
Ann Rheum Dis 2003; 62: 222-226.

Palmer SH.
Routine pathological examination of surgical specimens from patients undergoing total hip and knee replacement.
J Bone Joint Surg Am 2002; 84-A (6): 1082-1083.

Parvizi J, Johnson BG, Rowland C, Ereth MH, Lewallen DG.
Thirty-day mortality after elective total hip arthroplasty.
J Bone Joint Surg Am 2001; 83-A (10): 1524-1528.

Phillips CB, Barrett JA, Losina E, Mahomed NN, Lingard EA, Guadagnoli E, Baron JA, Harris WH, Poss R, Katz JN.
Incidence Rates of Dislocation, Pulmonary Embolism, and Deep Infection During the First Six Months After Elective Total Hip Replacement.
The Journal of Bone and joint surgery 2003; 85-A (1): 20-26.

Reginster J-Y, Deroisy R, Dougados M, Jupsin I, Colette J, Roux C.
Prevention of Early Postmenopausal Bone Loss by Strontium Ranelate: The Randomized, Two-Year, Double-Masked, Dose-Ranging, Placebo-Controlled PREVOS Trial.
Osteoporosis International 2002; 13: 925-931.

Scottish Intercollegiate Guidelines Network (SIGN).
Antibiotic Prophylaxis in Surgery: A National Clinical Guideline. SIGN Publication 45. 2000.
www.sign.ac.uk/guidelines/fulltext/45/index.html (Recherchedatum: 11.06.2007).

Seagroatt V, Tan HS, Goldacre M, Bulstrode C, Nugent I, Gill L.
Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality.
BMJ 1991; 303 (6815): 1431-1435.

Sharkey PF, Shastri S, Teloken MA, Parvizi J, Hozack WJ, Rothman RH.
Relationship between surgical volume and early outcomes of total hip arthroplasty: do results continue to get better?
J Arthroplasty 2004; 19 (6): 694-699.

Sharrock NE, Cazan MG, Hargett MJ, Williams-Russo P, Wilson PD Jr.
Changes in mortality after total hip and knee arthroplasty over a ten-year period.
Anesth Analg 1995; 80 (2): 242-248.

Stürmer KM.
Leitlinien Unfallchirurgie. Stürmer KM (Hrsg.). 2., unveränderte Auflage.
Stuttgart. Georg Thieme Verlag; 1999.

Valen B.
[Luxation of hip prosthesis].
Tidsskr Nor Laegeforen 2001; 121 (26): 3054-3056.

Woolson ST, Rahimtoola ZO.
Risk Factors for Dislocation During the First 3 Months After Primary Total Hip Replacement.
The Journal of Arthroplasty 1999; 14 (6): 662-668.

Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, Leeb B, Lequesne M, Lohmander S, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Swoboda B, Varatojo R, Verbruggen G, Zimmermann-Gorska I, Dougados M, EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
Ann Rheum Dis 2005; 64 (5): 669-681.